Bravecto Chews For Dogs 22-44 Lbs (10-20 Kg)

Bravecto Chews for Dogs 22-44 lbs (10-20 kg) 

Bravecto Chews for Dogs 22-44 lbs (10-20 kg) is a highly effective and tasty oral treatment designed to protect large dogs from fleas and ticks. This chewable tablet works efficiently, killing approximately 99% of fleas and ticks within a few hours of administration. Formulated with the active ingredient Fluralaner, Bravecto for dogs provides 12 weeks of continuous protection against fleas and common tick species, including black-legged ticks, American dog ticks, and brown dog ticks. Additionally, it controls flea-borne diseases and Flea Allergy Dermatitis, ensuring your dog remains healthy and comfortable. For added convenience, Bravecto Chews offer a delicious flavor that dogs love, making administration easy and stress-free.

Indications

Bravecto Chews for Dogs 22-44 lbs (10-20 kg) are designed to kill adult fleas and provide treatment and prevention of flea infestations (Ctenocephalides felis) for up to 12 weeks. Additionally, Bravecto treats and controls tick infestations, including black-legged ticks (Ixodes scapularis), American dog ticks (Dermacentor variabilis), brown dog ticks (Rhipicephalus sanguineus), and Asian longhorned ticks (Haemaphysalis longicornis) for 12 weeks. It also effectively treats and controls lone star tick (Amblyomma americanum) infestations for 8 weeks. Bravecto is suitable for dogs and puppies 6 months of age and older, weighing 22 pounds or more.

Possible Side Effects

The most commonly reported side effects of Bravecto Chews include vomiting, decreased appetite, diarrhea, lethargy, increased thirst, and flatulence. Seizures have been reported in dogs taking isoxazoline class drugs, including those with no prior history of seizures. Use Bravecto with caution in dogs with a history of seizures or neurological disorders.

Precautions

Fluralaner, the active ingredient in Bravecto, belongs to the isoxazoline class, which has been associated with neurologic adverse reactions such as tremors, ataxia, and seizures. Seizures have been reported in dogs taking isoxazoline drugs, even in those without a prior history of seizures. Therefore, use Bravecto with caution in dogs with a history of seizures or neurological disorders. Bravecto has not been proven effective for a 12-week duration in puppies under 6 months of age and is not effective against Lone Star ticks beyond 8 weeks of dosing.

Bravecto Protective Measures

• Not for Human Consumption: Bravecto is intended for use in dogs only.
• Use with Caution: Use Bravecto with caution in dogs with a history of seizures or neurologic disorders, as isoxazoline class drugs have been associated with neurologic adverse reactions such as tremors, ataxia, and seizures.
• Effectiveness Limitations: Bravecto is not effective against the lone star tick beyond 8 weeks of dosing.
• Consult Your Vet: Consult your veterinarian before using Bravecto in breeding females.
• Storage and Handling: Keep the tablet out of reach of pets and children. Do not open the package until required. Avoid eating, drinking, and smoking while administering the dosage. Wash hands with soap and water after handling the chew.

Contraindications

• Bravecto is contraindicated for use in dogs with known hypersensitivity to fluralaner or any of the product’s components.
• Do not use Bravecto in dogs that have shown adverse reactions to isoxazoline class drugs.
• Bravecto is also contraindicated in puppies less than 6 months of age and dogs weighing less than 4.4 pounds (2 kg).